Trials / Completed
CompletedNCT00588705
The Communication of Genetic Risk to Adolescent Daughters of Women With Breast Cancer
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 27 (actual)
- Sponsor
- Memorial Sloan Kettering Cancer Center · Academic / Other
- Sex
- Female
- Age
- 12 Years – 20 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to first understand how MSKCC Clinical Genetics Service doctors talk to women with breast cancer about any genetic risks they might carry, and if they help women to think about what they might say, in turn, to their relatives, especially their daughters. A second part of the study asks women for their opinions about when and how their daughters should be told about any genetic risks. All of this will help us develop teaching methods to help our doctors improve the way they talk about genetic risk when women with breast cancer have adolescent daughters.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | focus group & questionaire | The focus group will last about 90 minutes. However, your involvement in this study will last from the time you join until you read over the summary of what happened during the focus group and return your comments. This should be approximately 2 months. Patient will complete a questionnaire and we estimate total time for completion to be approximately 7 minutes. |
Timeline
- Start date
- 2007-12-01
- Primary completion
- 2017-01-01
- Completion
- 2017-01-01
- First posted
- 2008-01-08
- Last updated
- 2017-01-30
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00588705. Inclusion in this directory is not an endorsement.